Cite

HARVARD Citation

    Vera Aguilera, J. et al. (2018). Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG‐N0377, Alliance). Oncologist. pp. 887-e94. [Online]. 
  
Back to record